Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

125. Autoimmune progesterone dermatitis - Sirolimus for KP rubra - Spironolactone does not cause cancer - Dupi -> Th17/23 issues - Berdazimer for molluscum

125. Autoimmune progesterone dermatitis - Sirolimus for KP rubra - Spironolactone does not cause cancer - Dupi -> Th17/23 issues - Berdazimer for moll…

FromDermasphere - The Dermatology Podcast


125. Autoimmune progesterone dermatitis - Sirolimus for KP rubra - Spironolactone does not cause cancer - Dupi -> Th17/23 issues - Berdazimer for moll…

FromDermasphere - The Dermatology Podcast

ratings:
Length:
61 minutes
Released:
Feb 19, 2024
Format:
Podcast episode

Description

Autoimmune progesterone dermatitis -
Sirolimus for KP rubra -
Spironolactone does not cause cancer -
Dupi -> Th17/23 issues -
Berdazimer for molluscum -
Want to donate to the cause? Do so here!
http://www.uofuhealth.org/dermasphere
Check out our video content on YouTube:
https://www.youtube.com/@dermaspherepodcast
and VuMedi!: https://www.vumedi.com/channel/dermasphere/
The University of Utah's Dermatology
ECHO: ⁠https://physicians.utah.edu/echo/dermatology-primarycare -
⁠ Connect with us!
- Web: ⁠https://dermaspherepodcast.com/⁠ - Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: https://www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast,
SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our
friends at:
- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)
- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn
more dermatology!)
Released:
Feb 19, 2024
Format:
Podcast episode

Titles in the series (100)

For dermatology practitioners, Dermasphere covers the most important updates from the latest articles and research in the field. Maybe you don’t have time to read the journals—but we hope you have time to listen to a podcast about them!